Brand v. State

941 So. 2d 318, 2006 WL 1121156
CourtCourt of Criminal Appeals of Alabama
DecidedApril 28, 2006
DocketCR-04-1882
StatusPublished
Cited by9 cases

This text of 941 So. 2d 318 (Brand v. State) is published on Counsel Stack Legal Research, covering Court of Criminal Appeals of Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brand v. State, 941 So. 2d 318, 2006 WL 1121156 (Ala. Ct. App. 2006).

Opinion

Matthew Grant Brand appeals his April 12, 2005, conviction by the Franklin County Circuit Court of unlawful manufacture of a controlled substance in violation of § 13A-12-217, Ala. Code 1975; unlawful possession of marijuana in the second degree in violation of § 13A-12-214, Ala. Code 1975; and possession of drug paraphernalia in violation of § 13A-12-260, Ala. Code 1975. On May 25, 2005, the trial court sentenced Brand to 15 years' imprisonment; that sentence was split and Brand was ordered to serve 2 years for the conviction for unlawful manufacture of a controlled substance, one year for the conviction for second-degree marijuana possession, *Page 320 and six months for the drug-paraphernalia conviction. He was also ordered to pay $150 to the Crime Victims Compensation Fund in accordance with § 15-23-17(b), Ala. Code 1975, and $100 to the Forensic Trust Fund in accordance with § 36-18-7, Ala. Code 1975.

On January 2, 2002, Russelville Police officer Scotty Lowry received a telephone call from the manager of the Russelville Wal-Mart discount department store notifying him that two white males had purchased materials that could be used in the manufacture of methamphetamine. The manager also provided Officer Lowry the tag number of the automobile in which the individuals left the Wal-Mart parking lot. The vehicle, which was unoccupied, was located in the parking lot of the Franklin Shopping Center. Police set up surveillance and watched as Brand and Morgan exited Rite-Aid pharmacy and entered the vehicle. Police saw several bags inside the vehicle in plain view; some of them were transparent and contained boxes of cold and allergy medications.

The evidence indicated that at 10:43 a.m. on January 2, 2002, Brand purchased three boxes of allergy medicine containing pseudoephedrine and three packages of AA lithium batteries from the Wal-Mart discount store. At 10:44 a.m. at a different cash register in the same Wal-Mart store, Morgan purchased three boxes of tablets containing pseudoephedrine. At 10:58 a.m., Brand purchased three boxes of tablets containing pseudoephedrine at the Russellville Family Dollar discount store. At 11:08 a.m., Brand purchased from the Rite-Aid store in Russellville 3 boxes of 48-count tablets containing pseudoephedrine. At 11:11 a.m., Morgan purchased 2 boxes of 48-count tablets containing pseudoephedrine at the same Rite-Aid. In total, Brand and Morgan had purchased 14 boxes of medicines containing pseudoephedrine in less than 30 minutes.

I.
As best as we can discern from Brand's brief,1 he appears to argue that the trial court committed reversible error when it permitted Officer Lowry to read the ingredients label on the boxes of medication that had been introduced as exhibits during the trial. As we have previously stated, "The question of admissibility of evidence is generally left to the discretion of the trial court, and the trial court's determination on that question will not be reversed except upon a clear showing of abuse of discretion." Kennedy v. State, 929 So.2d 515,519 (Ala.Crim.App. 2005), quoting Ex parte Loggins,771 So.2d 1093, 1103 (Ala. 2000).

During the trial, the State introduced into evidence boxes of cold and allergy medicine purchased by Brand on January 2, 2002. The State then asked Officer Lowry to read the ingredients listed on each box. Brand objected, contending the information contained on the box was hearsay. The trial judge overruled the objections. *Page 321

Hearsay is defined as "a statement, other than one made by the declarant while testifying at the trial or hearing, offered in evidence to prove the truth of the matter asserted." Rule 801(c), Ala. R. Evid. Generally, hearsay is not admissible, unless it comes within an exception by the Alabama Rules of Evidence, by statute, or by other rules adopted by the Supreme Court of Alabama. Rule 802, Ala. R. Evid. In this matter, the label on a medicine box is hearsay because it is a written assertion "other than one made by the declarant while testifying at the trial or hearing, offered in evidence to prove the truth of the matter asserted" and would not be admissible unless some exception applied. Rules 801(c) 802, Ala. R. Evid.

However, Rule 803(17), Ala. R. Evid., provides that "[m]arket quotations, tabulations, lists, directories, or other published complications, generally used and relied upon by the public and by persons in particular occupations" are excluded from the hearsay rule. The question whether pharmaceutical labeling falls within this exception to the hearsay rule is one of first impression for Alabama appellate courts.

Given the widespread epidemic of illegal methamphetamine production, other jurisdictions with rules identical to Rule 803(17), Ala. R. Evid., have addressed this issue. In Statev. Heuser, 661 N.W.2d 157 (Iowa 2003), the Iowa Supreme Court held that pharmaceutical labeling falls within the market-report exception to the Iowa Rules of Evidence, which exception is identical to Alabama's Rule 803(17). Regarding the labels of boxes of cold medication, the Iowa Supreme Court held:

"The applicable state and federal regulations suggest the cold medication labels are accurate and trustworthy. Additionally, the contemporary nature of pharmaceutical practice exemplifies the inherent trustworthiness of cold medication labels.

"`In this modern day, thousands of pharmaceuticals are compounded, processed, or produced, and then packaged and labeled for distribution in that package for direct sale to a customer unopened, and frequently under seal, and as the modern advertising puts it "untouched by human hands." This is no longer an age when the processor puts the ingredients into a vial with an "eye-dropper," with highly variable results appearing in the finished "preparation," but an era characterized by automatic mixing, measuring, and filling apparatus, the entire productive process being controlled by electronic and nucleonic gauges, measuring to infinitesimal precision, to produce an absolute result in meeting a required standard. This is the process that brings to a pharmacist an "exempt" preparation, properly labeled as required by statute, and in this case a label . . . specifically designed to make that preparation more quickly identifiable.'

"State v. Mitchell, 18 Ohio App.2d 1, 246 N.E.2d 586, 589 (1969). For all these reasons, over-the-counter drug labels are generally relied upon as accurate."

661 N.W.2d 157, 164 (Iowa 2003).

Using the same reasoning as the Heuser court, the Indiana Supreme Court likewise held that cold-medicine labeling falls within Indiana's "market report" exception, which is identical to Alabama's "market report" exception to the hearsay rule. Reemer v. State, 835 N.E.2d 1005 (Ind. 2005). The Mississippi Supreme Court, relying on the reasoning of

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
N.D. Alabama, 2026
Commonwealth v. Amanda K. Berube
Massachusetts Appeals Court, 2025
Environmentel, Llc Vs. Kurian C/W 76199
Nevada Supreme Court, 2020
State v. Reay
2009 SD 10 (South Dakota Supreme Court, 2009)
State v. Anderson
220 S.W.3d 454 (Missouri Court of Appeals, 2007)
State v. Woodall
988 So. 2d 1065 (Court of Criminal Appeals of Alabama, 2007)
State v. Wilson
961 So. 2d 913 (Court of Criminal Appeals of Alabama, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
941 So. 2d 318, 2006 WL 1121156, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brand-v-state-alacrimapp-2006.